Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
QuintilesIMS
Harvard Business School
UBS
Chubb
US Department of Justice
Boehringer Ingelheim
Cerilliant
Deloitte

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,534,070

« Back to Dashboard

Which drugs does patent 6,534,070 protect, and when does it expire?

Patent 6,534,070 protects FINACEA and is included in one NDA.

This patent has thirty patent family members in twenty-four countries.
Summary for Patent: 6,534,070
Title: Composition with azelaic acid
Abstract:The invention relates to a pharmaceutical composition having the following constituents: azelaic acid, polyacrylic acid, triacylglyceride, propylene glycol, polysorbate, soya lecithin, water and salts. The composition is a hydrogel which is suited for the treatment of rosacea, presbyderma, melasma or skin irritations.
Inventor(s): Franke; Patrick (Berlin, DE), Gunther; Clemens (Berlin, DE), Riedl; Jutta (Inzlingen, DE)
Assignee: Schering Aktiengesellschaft (Berlin, DE)
Application Number:09/554,738
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,534,070
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Use;

Drugs Protected by US Patent 6,534,070

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Bayer Hlthcare FINACEA azelaic acid GEL;TOPICAL 021470-001 Dec 24, 2002 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,534,070

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany197 53 044Nov 19, 1997
Germany198 08 086Feb 20, 1998
PCT Information
PCT FiledNovember 18, 1998PCT Application Number:PCT/EP98/07370
PCT Publication Date:May 27, 1999PCT Publication Number: WO99/25332

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Julphar
Daiichi Sankyo
Merck
Dow
AstraZeneca
UBS
McKesson
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.